Kintara’s REM-001: A Breakthrough in Breast Cancer Cure
Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...
- Latest
- Trending
Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...
Diamondback Energy and Endeavor Energy Resources are set to merge in a $26 billion deal, boosting Diamondback shares. Other companies ...
Tango Therapeutics receives positive coverage from Piper Sandler, emphasizing its strong position in precision oncology. The firm believes the company's ...
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...
Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Amazon removes misleading books about King Charles' health and alleged cancer diagnosis from its platform, emphasizing its commitment to content ...
John Flavin, CEO of life sciences VC firm Portal Innovations, discusses the importance of intertwining real estate investments with their ...
Find out the dates and highlights of TAGCON, the annual gaming convention in the Tri-City area. Enjoy an extensive board ...
"Allegations of research fakery at Dana-Farber Cancer Institute shine light on scientific integrity and the role of amateur investigators. Learn ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.